Premium Subscribers: Complete your KYC to Avoid
Service Suspension. Login Here.

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NCC vs CONSTRONICS INFRA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NCC CONSTRONICS INFRA NCC/
CONSTRONICS INFRA		  
P/E (TTM) x 10.8 16.8 64.2% View Chart
P/BV x 1.1 2.0 55.9% View Chart
Dividend Yield % 1.7 0.0 -  

Financials

 NCC   CONSTRONICS INFRA
EQUITY SHARE DATA
    NCC
Mar-25		 CONSTRONICS INFRA
Mar-25		 NCC/
CONSTRONICS INFRA		 5-Yr Chart
Click to enlarge
High Rs365158 231.1%   
Low Rs17040 424.9%   
Sales per share (Unadj.) Rs353.640.7 869.1%  
Earnings per share (Unadj.) Rs13.82.5 553.2%  
Cash flow per share (Unadj.) Rs17.32.6 652.1%  
Dividends per share (Unadj.) Rs2.200-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs116.624.3 480.1%  
Shares outstanding (eoy) m627.8512.53 5,010.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.82.4 31.1%   
Avg P/E ratio x19.339.5 48.9%  
P/CF ratio (eoy) x15.537.3 41.5%  
Price / Book Value ratio x2.34.1 56.3%  
Dividend payout %15.90-   
Avg Mkt Cap Rs m167,7761,238 13,546.8%   
No. of employees `000NANA-   
Total wages/salary Rs m7,8889 86,115.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m221,994510 43,549.5%  
Other income Rs m1,55615 10,107.2%   
Total revenues Rs m223,549525 42,570.2%   
Gross profit Rs m19,27732 60,908.1%  
Depreciation Rs m2,1592 116,075.3%   
Interest Rs m6,8011 472,298.6%   
Profit before tax Rs m11,87344 27,137.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,19012 25,666.1%   
Profit after tax Rs m8,68331 27,721.9%  
Gross profit margin %8.76.2 139.8%  
Effective tax rate %26.928.4 94.6%   
Net profit margin %3.96.1 63.7%  
BALANCE SHEET DATA
Current assets Rs m176,345264 66,863.3%   
Current liabilities Rs m131,28091 144,693.4%   
Net working cap to sales %20.333.9 59.8%  
Current ratio x1.32.9 46.2%  
Inventory Days Days27148 18.3%  
Debtors Days Days6416 1.3%  
Net fixed assets Rs m33,269219 15,222.4%   
Share capital Rs m1,256125 1,002.2%   
"Free" reserves Rs m71,981179 40,181.6%   
Net worth Rs m73,237304 24,057.1%   
Long term debt Rs m2,6460-   
Total assets Rs m209,614482 43,461.3%  
Interest coverage x2.731.4 8.8%   
Debt to equity ratio x00-  
Sales to assets ratio x1.11.1 100.2%   
Return on assets %7.46.8 108.8%  
Return on equity %11.910.3 115.2%  
Return on capital %24.614.8 165.8%  
Exports to sales %00-   
Imports to sales %0.10-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m223NA-   
Fx inflow Rs m00-   
Fx outflow Rs m2370-   
Net fx Rs m-2370-   
CASH FLOW
From Operations Rs m7,417-262 -2,830.1%  
From Investments Rs m-586-8 7,775.6%  
From Financial Activity Rs m-2,467289 -853.2%  
Net Cashflow Rs m4,36520 22,360.1%  

Share Holding

Indian Promoters % 22.3 10.6 209.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 26.8 0.0 -  
FIIs % 11.5 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 77.8 89.4 87.0%  
Shareholders   569,370 3,883 14,663.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NCC With:   L&T    IRCON INTERNATIONAL    ENGINEERS INDIA    OM INFRA    J KUMAR INFRA    


More on NCC vs INNOVATION MEDICAL

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

NCC vs INNOVATION MEDICAL Share Price Performance

Period NCC INNOVATION MEDICAL S&P BSE REALTY
1-Day -6.57% -3.66% -4.75%
1-Month -12.22% 0.93% -18.99%
1-Year -37.13% -40.02% -24.12%
3-Year CAGR 7.48% 98.43% 18.29%
5-Year CAGR 10.19% 48.21% 13.64%

* Compound Annual Growth Rate

Here are more details on the NCC share price and the INNOVATION MEDICAL share price.

Moving on to shareholding structures...

The promoters of NCC hold a 22.3% stake in the company. In case of INNOVATION MEDICAL the stake stands at 10.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NCC and the shareholding pattern of INNOVATION MEDICAL.

Finally, a word on dividends...

In the most recent financial year, NCC paid a dividend of Rs 2.2 per share. This amounted to a Dividend Payout ratio of 15.9%.

INNOVATION MEDICAL paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of NCC, and the dividend history of INNOVATION MEDICAL.



Today's Market

Sensex Today Tanks 1,836 Points | Nifty Below 22,550 | Petronet LNG Down 8% Sensex Today Tanks 1,836 Points | Nifty Below 22,550 | Petronet LNG Down 8%(Closing)

Although the benchmark indices opened lower, they traded negative throughout the session and ultimately closed red.

ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Quantum Information Services Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

  • Registered Name:

    Quantum Information Services Private Limited

  • Registered Office Address:

    103, Regent Chambers, Nariman Point, Mumbai 400021

  • CIN:

    U65990MH1989PTC054667

  • Website:

    www.equitymaster.com

  • Compliance Officer & Grievance Officer:

    Ms. Sonal Ramachandran

    | Telephone No.: +91-22-61434003 | Email: compliance@equitymaster.com

SEBI Registered Research Analyst Details:

SEBI Registration No.: INH000021128 | Type of Registration: Non-Individual | Validity: Perpetual | BSE Enlistment No: 6769

Principal Officer: Tanushree Banerjee | Telephone No.:+91-22-61434055 | Email: po.ra@equitymaster.com

SEBI Registered Investment Adviser Details:

SEBI Registration No.: INA000000680 | Type of Registration: Non-Individual | Validity: Perpetual | BSE Enlistment No: 1488

Principal Officer: Vivek Chaurasia | Telephone No.:+91-22-61434055 | Email: po.ria@equitymaster.com

SEBI Office Details:

SEBI Bhavan BKC
Address: Plot No.C4-A, 'G' Block Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra
Telephone No.: +91-22-26449000 / 40459000 | Fax: +91-22-26449019-22 / 40459019-22 | Email: sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575
SCORES: https://www.scores.gov.in/ | SMARTODR: https://smartodr.in/login

Association of Mutual Funds of India (AMFI) Registered Details:

AMFI Registered Mutual Fund Distributor
AMFI Registration Number : ARN - 1022
Date of Initial Registration : 28 / JAN / 2008
Current Validity of ARN upto : 28 / JAN / 2028

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI, enlistment with BSE as IA and RA, and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing any content from this website whether wholly or in part, for any purpose without the permission of Quantum Information Services Private Limited is strictly prohibited and shall be deemed to be copyright infringement.

Quantum Information Services Private Limited (QIS) is a SEBI registered Research Analyst (bearing registration no INH000021128) and Investment Adviser(Reg. No: INA000000680). Consequent upon the merger of Equitymaster Research Private Limited into QIS, effective October 30, 2025 QIS owns and operates brand 'Equitymaster' and website www.equitymaster.com. This does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities and QIS including its employees, personnel, directors, associates will not be liable for any losses (direct or indirect) incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. All content and information is provided on an 'As Is' basis by QIS. Information herein is believed to be reliable but QIS does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. The services rendered by QIS are on a best effort basis. QIS does not assure or guarantee the user any minimum or fixed returns. The securities quoted, if any are for illustration only and are not recommendatory. Use of this information is at the user's own risk. The user must make his own investment decisions based on his specific investment objective and financial position and using such independent advisors as he believes necessary. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject QIS or its affiliates to any registration or licensing requirement.

The performance data quoted represents past performance and does not guarantee future results. As a condition to accessing QIS's content and website, you agree to our Terms and Conditions of Use, available here.